Susan Sam is an Endocrinology/Metabolic physician affiliated with University of Chicago. OpenAlex indexes 24 publications with 1,163 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
67.2%GLP-1 receptor agonist23.6%Ozempic67%Trulicity17%Mounjaro9%Rybelsus7%Part D<11 patientsInsulin Analog18.4%Lantus Solostar35%Basaglar Kwikpen U-10033%Novolog Flexpen22%Humalog Kwikpen U-10010%Part D≥31 patients+ 5 more classes in this area
Hormonal (systemic)
19.6%l-Thyroxine12.7%Levothyroxine Sodium100%Part D≥42 patientsThyroid Hormone Synthesis Inhibitor3.7%Methimazole100%Part D≥11 patients+ 2 more classes in this area
Cardiovascular
8.7%Statin6.1%Atorvastatin Calcium71%Rosuvastatin Calcium29%Part D<11 patientsACE inhibitor2.5%Lisinopril100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2011 per NIH RePORTER. The latest:
- Adipose Tissue and Insulin Resistance in Polycystic Ovary Syndrome
University of Illinois at Chicago
FY2011$166,854K23DK080988 - Adipose Tissue and Insulin Resistance in Polycystic Ovary Syndrome
University of Illinois at Chicago
FY2010$166,854K23DK080988 - Adipose Tissue and Insulin Resistance in Polycystic Ovary Syndrome
University of Illinois at Chicago
FY2009$166,854K23DK080988
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bilateral Adrenalectomy Versus Medical Management for Cushing’s Syndrome with Bilateral Adrenal Hyperplasia
Difficult decisions in surgery: an evidence-based approach
2025 - Role of obstructive sleep apnea in metabolic risk in PCOS
Current Opinion in Endocrine and Metabolic Research
2021 - SUN-187 A Case of Adrenal Mass with Elevated ACTH and Cortisol in a Woman with No Cushingoid Features
Journal of the Endocrine Society
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”